Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Bayer A.G. (OTC: BAYRY).

Full DD Report for BAYRY

You must become a subscriber to view this report.


Recent News from (OTC: BAYRY)

Your Cancer Highlight: Chi-Med Looks To Dominate Colorectal Cancer In China
Colorectal cancer ((CRC)) is one of the more difficult and controversial forms of cancer that we face. In America and many parts of Europe, the screening efforts we undertake allow us to catch a lot of cases in the earliest stages, where they can be effectively cured by a pretty simple procedu...
Source: SeekingAlpha
Date: September, 06 2018 08:00
Bayer A.G. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Bayer A.G. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: September, 05 2018 13:58
Bayer says hit by 8,700 lawsuits over glyphosate, cuts 2018 profit outlook
Bayer ( OTCPK:BAYRY -1.4% ) says it faces 8,700 lawsuits related to Monsanto's glyphosate weedkiller products, compared with ~5,200 earlier this year, mostly from cancer patients who claims to have fallen ill after being exposed to one of the products. More news on: Bayer A.G. ADR, ...
Source: SeekingAlpha
Date: September, 05 2018 10:59
Compugen, 'From Code To Cure': Becoming A Clinical-Stage Company
With a market cap of only $225 million (including $43 million in cash as of June 30th), Compugen Ltd. ( CGEN ) has the potential to deliver outsized returns for shareholders over the next 12 to 24 months. Since publishing my initial article on Compugen on SA on February 20, 2018, Compugen ...
Source: SeekingAlpha
Date: September, 05 2018 10:11
Big Tech To Testify Before Senate (Wall Street Breakfast Podcast)
Today's top stories: Big tech to testify before Senate; U.S.-Canada NAFTA talks continue; and J.D.com CEO Richard Liu accused of rape. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Al...
Source: SeekingAlpha
Date: September, 05 2018 07:48
Wall Street Breakfast: No Relief For Emerging Markets
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes , Stitcher and SoundCloud (click the highlighted links). An emerging market selloff focused on Argentina and Turkey has begun to spread to other major economies in the dev...
Source: SeekingAlpha
Date: September, 05 2018 07:01
Bayer commits to Monsanto amid profit warning
Bayer's ( OTCPK:BAYRY ) $63B Monsanto purchase has suffered regulatory delays, legal battles over Roundup herbicide and now will yield lower earnings than earlier forecast, but the company's CEO said he has "no regrets." More news on: Bayer A.G. ADR, Bayer A.G., Earnings news and comment...
Source: SeekingAlpha
Date: September, 05 2018 05:34
Biotech Analysis Central Pharma News: Pfizer Axes Drug, Merck's Approvals, Bayer's Green Light
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Pfizer Dumps DMD Drug After Trial Failures News: Recently, Pfizer ( PFE ) announced that it had failed two studies treating patients with duchenne...
Source: SeekingAlpha
Date: September, 04 2018 23:59
Bayer mulling job cuts and outsourcing in pharma R&D operations
Reuters reports that Bayer ( OTCPK:BAYRY -1.1% ) is considering headcount reductions and outsourcing in its pharma R&D operations in order to improve efficiency and give it additional financial flexibility for targeted acquisitions of promising treatments. More news on: Bayer A.G. ...
Source: SeekingAlpha
Date: September, 04 2018 12:30
Brazil court overturns ban on glyphosate weedkiller
A Brazilian court yesterday overturned an injunction banning products containing the popular weedkiller glyphosate, refuting a previous ruling that had been set to disrupt the soy planting season set to begin this month. More news on: Bayer A.G. ADR, Commodities news, Read more ...
Source: SeekingAlpha
Date: September, 04 2018 11:47

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-11-1617.8317.9218.0517.74652,598
2018-11-1518.0618.2418.3317.85698,904
2018-11-1418.72518.2518.7418.17627,309
2018-11-1318.6818.71518.8518.57956,608
2018-11-1219.4719.3119.5919.24564,151

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-16127,983649,39819.7079Cover
2018-11-15130,185685,04519.0039Cover
2018-11-14150,804617,10924.4372Cover
2018-11-13280,160950,15229.4858Cover
2018-11-12196,485563,30134.8810Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BAYRY.


About Bayer A.G. (OTC: BAYRY)

Logo for Bayer A.G. (OTC: BAYRY)

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high tech materials. At the same time Bayer creates value through innovation, growth and improved earning power. lt br / gt lt br / gt Bayer HealthCare AG researches, develops, manufactures and markets innovative products for disease prevention, diagnosis and treatment. Bayer CropScience AG is a global leader in crop protection and non agricultural pest control. Bayer MaterialScience AG is a renowned supplier of high performance materials and innovative system solutions used in a wide range of products for everyday life. lt br / gt lt br / gt The Group is committed to the principles of sustainable development and acknowledges and accepts its role as a socially and ethically responsible corporate citizen, Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal , More information is available on the Internet at www.investor.bayer.com.

 

 

 

Current Management

  • Dr. Marijn Dekkers / CEO
  • Werner Wenning / CFO
  • Martin Eisenhauer / Securities Counsel
  • Peter Dahlhoff / IR

Current Share Structure

     



    Daily Technical Chart for (OTC: BAYRY)

    Daily Technical Chart for (OTC: BAYRY)


    Stay tuned for daily updates and more on (OTC: BAYRY)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: BAYRY)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BAYRY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BAYRY and does not buy, sell, or trade any shares of BAYRY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/